Journal article

HIV vaccine rationale, design and testing

KS Slobod, C Coleclough, M Bonsignori, SA Brown, XY Zhan, S Surman, A Zirkel, BG Jones, RE Sealy, J Stambas, B Brown, TD Lockey, PJ Freiden, PC Doherty, JL Blanchard, LN Martin, JL Hurwitz

CURRENT HIV RESEARCH | BENTHAM SCIENCE PUBL LTD | Published : 2005

Abstract

A central obstacle to the design of a global HIV vaccine is viral diversity. Antigenic differences in envelope proteins result in distinct HIV serotypes, operationally defined such that antibodies raised against envelope molecules from one serotype will not bind envelope molecules from a different serotype. The existence of serotypes has presented a similar challenge to vaccine development against other pathogens. In such cases, antigenic diversity has been addressed by vaccine design. For example, the poliovirus vaccine includes three serotypes of poliovirus, and Pneumovax presents a cocktail of 23 pneumococcal variants to the immune system. It is likely that a successful vaccine for HIV mu..

View full abstract